Dynamic growth of pharmaceutical sales to hospitals in Poland

13 November 2014

The year 2013 was better for the Polish pharmaceutical distribution market than 2012, when wholesale sales to pharmacies and the retail pharmacy market both shrank in the immediate aftermath of the Reimbursement Act, a new report from Poland-based research firm PMR finds.

Titled “Distribution on the pharmaceutical market in Poland 2014. Development forecasts for 2014-2019,” the study shows that sales to hospitals have now emerged as the fastest-growing segment of pharmaceutical distribution in Poland.

Pharmacy market growth to pick up only from 2015 onwards

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >